American Diversified Holdings Corporation (PK) (ADHC) 시세

Think hes long gone, but there are other promoters all over pumping this crap.

crown king still here?

Kind of looks that way. I guess if you are going to tout a device you should probably have a device.

Paid to promote the stock per his disclosure.

$ADHC $ADHC GlucoGuard currently awaiting decision from FDA for breakthrough device designation

I really like the stock down here, lot of upside with major catalyst ahead

GlucoGuard also has a partnership with Dexcom $DXCM, a $30 Billion dollar company$RDGL $MRES $BIXT $IGEX $GTVH https://t.co/U7pbHODM9G pic.twitter.com/X51heyAVA2— Stock Picks NYC (@StockPicksNYC) March 10, 2025

Maybe I am missing something here. Didn't they say they are debt free??
We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term.

Hes associated with paid promoters. It shouldnt surprise you.

PA rarely lies; this ticker is heading back to test its lows of .0006 from last summer. Complete reset of chart, but now with an enormous amount of overhead supply. This management team needs to firm themselves. This one turned into a real shit show.

lol, why the surprise?

WTF, headed lower, again!

Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.

@ADHCMANAGEMENT
$ADHC
Glucoguard team responding to FDA comments this week, more developments expected on AI alliance and Glucoguard Develoopments soon
11:50 AM · Feb 26, 2025
·

and its down unreal you still pumping otc

BooYaaaaaaaaa

$ADHC The Breakthrough Devices Program is intended to provide patients and health care providers with timely access to medical devices by speeding up development, assessment, and review for premarket approval, 510(k) clearance, and De Novo marketing authorization. Breakthrough Devices must meet the FDA's rigorous standards for device safety and effectiveness in order to be authorized for marketing. The Breakthrough Devices Program reflects the FDA's commitment to device innovation and protecting the public health.

"We have received initial feedback back from the FDA indicating the application is qualified for review, we expect to hear back with comments from the reviewer in the near future and are optimistic that the GlucoGuard technology presents a compelling case for approval," commented the GlucoGuard team.

This FDA application combined with the recent announcement regarding Continuous Glucose Monitoring (CGM) with development partner Dexcomm has moved the development of this technology along rapidly. More negotiations with Investment Partners are in place and shareholders will be informed in the near future.

$ADHC https://finance.yahoo.com/news/glucoguard-files-breakthrough-device-application-143500630.html

FDA news nice https://www.otcmarkets.com/stock/ADHC/news/story?e&id=3154840

Did their funding run out to pay you?

$ADHC Update! @ADHCMANAGEMENT $ADHC pic.twitter.com/SOHrjBd0Gp— ADHC MANAGEMENT $ADHC (@ADHCMANAGEMENT) February 25, 2025

How are they going to pay for the FDA clinical trials. This company is not J&J or Moderno. So far they only pay their bills with shares. That is a red flag issue right there. Remo stepped down,REALLY. He has more shares than anyone else period. Maybe they should change the name to glucofraud.

Correct this is a pos

I added a few!
$ADHC @ADHCMANAGEMENT
Glucoguard Update Scheduled for Wednesday, ADHC as a holding company is developing multiple business divisions
In Biodevice and AI/Cybersecurity

They have no FDA approval. Do they even have a product???
They do have REMO with 2 billion shares. That alone should give you confidence.

$ADHC https://www.techkahunas.com/
https://www.otcmarkets.com/stock/ADHC/news/story?e&id=3150894

$ADHC - So a company with 3 employees and no physical office is going to get involved in AI?
Yeah, sure. This reminds me of about 6 years ago where everyone was going to use "blockchain", or 3 years ago when everyone was going to mine bitcoin.
As soon as I saw that PR on AI, I dumped my multi millions of shares. I see I wasn't alone.
Good luck with this one.

bad idea imo! The PA in this ticker for the past 3 months has been a screaming sell! You have any clue as to how much supply is trapped from .0025 up to .005? The management in this company needs to fire themselves! There is no reason why this shouldn't be trading in the trips right now.

More great buying opportunity!

It's a bloodbath today
Huge volume though

$ADHC
@ADHCMANAGEMENT

Glucoguard Update Scheduled for Wednesday, ADHC as a holding company is developing multiple business divisions
In Biodevice and AI/Cybersecurity
6:48 AM · Feb 24, 2025

nice news out https://www.otcmarkets.com/stock/ADHC/news/story?e&id=3150894

You left off a zero on the left side.😀

Your right. Nothing but CLOWN TALK with no substance.
Sounds like a Kamala Harris word salad.
Pass the oil & vinegar

saw that

This was the big announcement? Lol

agreed

@ADHCMANAGEMENT $ADHC

ADHC in discussion for major Artificial Intelligence AI initiative. Capitalizing on Mag 7 Artificial Intelligence 2025/26 Capex
Increases

Alphabet $ 75 B
Meta $60B and
Microsoft $80 B

Time to join the Fintech AI revolution— ADHC MANAGEMENT $ADHC (@ADHCMANAGEMENT) February 20, 2025

@ADHCMANAGEMENT $ADHC

ADHC in discussion for major Artificial Intelligence AI initiative. Capitalizing on Mag 7 Artificial Intelligence 2025/26 Capex
Increases

Alphabet $ 75 B
Meta $60B and
Microsoft $80 B

Time to join the Fintech AI revolution— ADHC MANAGEMENT $ADHC (@ADHCMANAGEMENT) February 20, 2025

Looking strong like bull

looking good here new highs this is set to go back to 004-005 with ease

nice close

Bids growing looks like it's ready to pop back the 2s

@ADHCMANAGEMENT $ADHC

Compelling Updates coming next week, ADHC team is hard at work building shareholder value!!!— ADHC MANAGEMENT $ADHC (@ADHCMANAGEMENT) February 14, 2025

took some down here so oversold and overdue for news, SS hasnt changed shouldnt be down here

Great trading day yesterday     was good to see

Until they post the truth about the FDA ruling, this is going nowhere.

Thanks

sure here it is.

@ADHCMANAGEMENT $ADHC

Press Release has been postponed due to expected weak market conditions, ADHC management is making significant progress
With Glucoguard Development, thx for your patience— ADHC MANAGEMENT $ADHC (@ADHCMANAGEMENT) February 3, 2025

The pr retraction the other day was honestly the most absurd thing I've seen by an OTC company in a while. Can you post that retraction on this board.

Surprised by this one I was! I really thought they'd run this play way better than it did. I said its heading back to trips and I see no reason why it shouldn't. They allowed the chart to be completely destroyed, and todays PA sets this up for a new low going back to the breakout from last August. Managment here are absolutely out of their league on how to move an OTC in a way that isn't an obvious pump and dump. The pr retraction the other day was honestly the most absurd thing I've seen by an OTC company in a while. They're going to have to come out with unreal PR's to move this thing now, sharks smell blood in the water! This loses .0011 well see trips within a day or two! Mark it!

Lol, nice PA, thank God they waited for a green day in the markets to deliver the huge news. LOL, Can't imagine what would of happened if they did it yesterday.